Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_assertion type Assertion NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_head.
- NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_assertion description "[CCL2 is also associated with tumor progression in several cancer types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_provenance.
- NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_assertion evidence source_evidence_literature NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_provenance.
- NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_assertion SIO_000772 23183267 NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_provenance.
- NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_assertion wasDerivedFrom befree-20150227 NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_provenance.
- NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_assertion wasGeneratedBy ECO_0000203 NP684730.RAf0PBOKoGK_ymh9zQqkxbDhmu-UvyVsj4K-N0TOLyyoQ130_provenance.